首页> 外文期刊>Nephron >Hospitalizations for valvular heart disease in chronic dialysis patients in the United States.
【24h】

Hospitalizations for valvular heart disease in chronic dialysis patients in the United States.

机译:美国慢性透析患者瓣膜性心脏病的住院治疗。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Valvular heart disease has not been studied in a national population of end stage renal disease patients. Methods: 327,993 dialysis patients in the United States Renal Data System initiated from 1 January 1992 to 30 June 1997 were analyzed in a historical cohort study of patients hospitalized for valvular heart disease (ICD9 Code 424.x, excluding endocarditis, and 394.x-397.x). Results: 2,778 dialysis patients were hospitalized for VHD (incidence rate, 3.57 per 1,000 person years), and dialysis patients had an age-adjusted incidence ratio for valvular heart disease of 5.06 (95% confidence interval, 4.00-6.42) compared to the general population in 1996. In Cox regression analysis, time to hospitalization for valvular heart disease was associated with earlier year of first dialysis, increased age, congestive heart failure and use of erythropoietin prior to dialysis, while African-American race (AHR 0.62, 0.52-0.74) was associated with decreased risk of hospitalization for valvular heart disease. Patients hospitalized for valvular heart disease had increased mortality compared to all other dialysis patients (adjusted hazard ratio by Cox regression 1.35, 95% CI, 1.25-1.46). Conclusions: Dialysis patients were at increased risk for hospitalizations for valvular heart disease compared to the general population, which substantially decreased patient survival. The reasons for the decreased risk of African-Americans on chronic dialysis for this complication should be the subject of future trials.
机译:背景:尚未在全国晚期肾病患者人群中研究过瓣膜性心脏病。方法:在1992年1月1日至1997年6月30日开始的美国肾脏数据系统中,对327993名透析患者进行了一项历史性队列研究,分析了接受瓣膜性心脏病住院治疗的患者(ICD9代码424.x,不包括心内膜炎和394.x- 397.x)。结果:2778名透析患者因VHD住院(发生率,每1000人年3.57),而透析患者的年龄调整后的瓣膜性心脏病的发生率是5.06(95%置信区间为4.00-6.42)。在1996年的Cox回归分析中,瓣膜性心脏病的住院时间与首次透析的早年,年龄增加,充血性心力衰竭以及透析前使用促红细胞生成素有关,而非裔美国人则与此相关(AHR 0.62,0.52- 0.74)与瓣膜性心脏病住院风险降低相关。与所有其他透析患者相比,住院的瓣膜性心脏病患者死亡率增加(通过Cox回归调整的危险比1.35、95%CI,1.25-1.46)。结论:与普通人群相比,透析患者的瓣膜性心脏病住院风险更高,这大大降低了患者的生存率。非裔美国人因这种并发症而接受慢性透析的风险降低的原因应作为未来研究的主题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号